revolutionizing access to health information
The Fluxergy Analyzer platform combines the capabilities of many machines into one multimodal system, delivering more affordable laboratory-quality test results and actionable metrics in 1 hour or less.
Request More Information
Addressing industry needs through collaboration
Our platform enable us to provide a diverse portfolio of assays designed to meet the needs of communities and markets around the world.
Request More Information
Designed and Manufactured in Irvine, California
We proudly develop our hardware, software, biologics, and consumables leveraging full design and production control.
Request More Information
Previous
Next
Accurate and Rapid PCR Testing at Pharmacies and Clinics
We deploy platforms in regions that accept CE-IVD to address community-based needs for COVID-19 and respiratory panel testing.
Stall-Side Pathogen Testing to Protect the Equine Industry
Improving in-clinic diagnostics with the release of a salmonella PCR assay and development of an EHV-1, S. equi, and respiratory panel assay.
On-Site Laboratory Testing for Food Production Facilities
Helping farmers, food manufacturers, and retailers enable faster in-process testing of pathogens and allergens.
Co-Development of Assays with Industry Leaders
Collaboration is part of Fluxergy’s value system: several companies are porting their assays onto the Fluxergy analyzer platform and consumable system to reach the point-of-care.
Personalized Medicine for Home and Chronic Care
Fluxergy is working on at-home hardware, software, and consumable technologies for people who can benefit from daily and weekly home testing.
Tackling Unmet Needs with a Novel Diagnostics Accelerator
Fluxergy has joined the Wyss Institute at Harvard to work with diagnostic stalwarts and technologies to address early diagnoses for several diseases.
Previous
Next

FLUXERGY'S 3 CORE TECHNOLOGIES

Trusted & Certified

These certifications demonstrate Fluxergy's commitment to compliance and effectiveness of our products and quality management system.

cgmp
iso 13485:2016
mdsap
ce ivd

Collaborate with Fluxergy

APPLICATIONS ACROSS INDUSTRIES

We deploy platforms in regions that accept CE-IVD to address community-based needs for COVID-19 and respiratory panel testing.

julia horse

Improving in-clinic diagnostics with the release of a Salmonella PCR assay and development of an EHV-1, S. equi equi, and respiratory panel assay.

Helping farmers, food manufacturers, and retailers enable faster in-process testing of pathogens and allergens.

fluxergy employees

Collaboration is part of Fluxergy’s value system: several companies are porting their assays onto the Fluxergy analyzer platform and consumable system to reach the point-of-care.

fluxergy works

Fluxergy is working on at-home hardware, software, and consumable technologies for people who can benefit from daily and weekly home testing.

wyss fluxergy

Fluxergy has joined the Wyss Institute at Harvard to work with diagnostic stalwarts and technologies to address early diagnoses for several diseases.

What Experts Say About Fluxergy

Who We Work With

Find Us Here

Featured In

*Only Fluxergy Test Kit COVID-19 has been approved for CE-IVD and is available for any markets that accept CE marking as the valid regulatory approval. All other products or any other markets are For Research Use Only (RUO) and are not for use in diagnostic procedures.

*This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Fluxergy takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
*Although forward-looking statements contained in this website regarding Fluxergy’s objectives, plans, goals, strategies, future growth, business prospects and opportunities are based upon what Fluxergy management believes are reasonable assumptions, estimates, and other judgments, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.